Articles Referencing NXTM

Covidien Issues STAR Trial Data - Analyst Blog

2/8/2013, 6:30 pm from Zacks.com in Investing, Business, Stocks

International health care products major, Covidien plc. ( COV ) announced results of the two-year "Solitaire FR Thrombectomy for Acute Revascularization (STAR)" study. Results of... Read >>

Covidien's 1Q Beats, Raises View - Analyst Blog

1/25/2013, 3:07 pm from Zacks.com in Investing, Business, Stocks

Covidien plc. ( COV ) reported its adjusted earnings per share of $1.10 for the first quarter of fiscal 2013, 4 cents above the Zacks Consensus Estimate but 3 cents lower than the year-ago... Read >>

LabCorp Remains at Neutral - Analyst Blog

1/15/2013, 2:30 pm from Zacks.com in Investing, Business, Stocks

We have reaffirmed our Neutral recommendation on Laboratory Corporation of America Holdings ( LH ), the second largest independent clinical laboratory company in the U.S. This was primarily... Read >>

Quest Diagnostics Remains at Neutral - Analyst Blog

1/15/2013, 1:13 pm from Zacks.com in Investing, Business, Stocks

We recently reiterated our Neutral recommendation on Quest Diagnostics ( DGX ), the leading providers of commercial laboratory services in North America. While we hold a favorable view... Read >>

Volcano Corporation Stays Neutral - Analyst Blog

1/11/2013, 10:50 am from Zacks.com in Investing, Business, Stocks

We have reaffirmed our Neutral recommendation on Volcano Corporation ( VOLC ) based on the company's disappointing third quarter 2012 and a sluggish prelim result for the fourth quarter... Read >>

Momentum Ideas: 6 Rallies Boosted by Hedge Funds and Short Seller Activity

11/17/2011, 6:37 pm from Kapitall in Investing, Investing Ideas, Stocks, US Markets

(Written by Alexander Crawford, list compiled by Eben Esterhuizen, CFA. Data from 11/14. Institutional data sourced from Fidelity, short data sourced from Yahoo! Finance, technical data sourced... Read >>